Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC7 | O00311 | 2/20 | 0.48 |
| ▸ | DBF4 | Q9UBU7 | 2/20 | 0.48 |
| ▸ | ICMT | O60725 | 8/20 | 0.47 |
| ▸ | XDH | P47989 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7886314 | 0.90 | ICMT (0.43) | CDC7DBF4ICMTXDHCNR1 | |
| SCHEMBL3705167 | 0.87 | XDH (0.55) | CDC7DBF4ICMTXDH | |
| SCHEMBL7894648 | 0.87 | ICMT (0.45) | ICMTXDHGSK3BCNR1CNR2 | |
| SCHEMBL7895901 | 0.81 | CDC7 (0.52) | CDC7DBF4XDH | |
| SCHEMBL7890347 | 0.80 | CDC7 (0.45) | CDC7DBF4DYRK1A | |
| SCHEMBL3707802 | 0.75 | CDC7 (0.51) | CDC7DBF4XDH | |
| SCHEMBL3707314 | 0.74 | XDH (0.49) | CDC7DBF4XDH | |
| SCHEMBL3715619 | 0.73 | XDH (0.58) | XDH | |
| SCHEMBL7883332 | 0.73 | CDC7 (0.56) | CDC7DBF4ICMT | |
| SCHEMBL3704109 | 0.72 | XDH (0.55) | CDC7DBF4ICMTXDH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010093191-A2 | NOVEL COMPOUNDS EFFECTIVE AS XANTHINE OXIDASE INHIBITORS, METHOD FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES LTD. (KR) | 2010-08-19 | — | — | WO | disclosed |